Novartis
Basel, Switzerland
East Hanover, New Jersey, United States
with other locations globally
United States
Website: https://www.novartis.com/
2206 articles about Novartis
-
Novartis AG (JOBS) Unit Gets EU Approval for Generic Biosimilar
2/13/2009
-
Novartis AG to Pay Portola Pharmaceuticals, Inc. $75 Million for Anti-clotting Drug; Portola to Receive $500 Million in Potential Milestone Payments Plus Royalties on Future Sales
2/12/2009
-
Novartis AG Bone Drugs May Help Fight Breast Cancer, Medical University of Vienna Study
2/12/2009
-
Hercules Technology’s Portfolio Company, Portola Pharmaceuticals, Inc., Has Entered Into a Worldwide License Agreement With Novartis AG
2/12/2009
-
Antisoma PLC's ASA404 To Be Developed In Breast Cancer
2/12/2009
-
Novartis AG $5 Billion Bond Sale Bolsters Takeover Funds
2/6/2009
-
Novartis AG Gets Approval to Market 4 Drugs in Japan
1/21/2009
-
US Government and Novartis AG in $486 Million Flu Vaccine Deal
1/15/2009
-
Novartis AG (JOBS) Licenses Vaccine Candidates from US Group, AlphaVax, Inc. for $20 Million
12/29/2008
-
Novartis Pharmaceuticals Corporation Release: Patients With Early Parkinson’s Disease Experienced Better Symptom Control And Improvements In Daily Activities With Stalevo(R) Than Carbidopa/Levodopa, According To Newly-Published Study
12/17/2008
-
MDRNA, Inc. Announces Tentative FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis
12/15/2008
-
Novartis Pharmaceuticals Corporation's Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
12/11/2008
-
FDA Sees Asthma Drug Risks, Seeks Panel Advice
12/5/2008
-
U.S. FDA Advisers Back Novartis AG Malaria Drug
12/4/2008
-
Mylan Inc., Novartis AG Agree on Femara Generic
12/2/2008
-
Emisphere Technologies, Inc. Announces Study Results Of New, Orally Bioavailable Formulation of Parathyroid Hormone ('Pth') Using Eligen(r) Technology
11/24/2008
-
Novartis AG (JOBS) to Combine Heart Pills as Afinitor Cancer Drug Delayed
11/20/2008
-
Novartis AG (JOBS) Prepares for Looming Loss of Diovan Patent
11/20/2008
-
Novartis AG (JOBS) Could Cut Drug Development by a Year; New Research Strategies Paying Off
11/20/2008
-
Novartis AG (JOBS), Pfizer Inc. (JOBS) Cancer Drugs Halt Type 1 Diabetes in Mice
11/18/2008